| Wei, Meng |
| Not yet recruiting | N/A | 2000 | RoW | Radiofrequency catheter ablation | First Affiliated Hospital Xi'an Jiaotong University, Shaanxi Provincial People's Hospital, 521 Hospital of NORINCO Group, Xiangyang Central Hospital, Ankang Central Hospital, Baoji Central Hospital, Luoyang Central Hospital, Tianjin Medical University Second Hospital, Fu Wai Hospital, Beijing, China, Fuwai Yunnan Cardiovascular Hospital, Chinese Academy of Medical Sciences, Fuwai Hospital | Arrhythmia, Acute Cerebrovascular Disease | 12/26 | 12/26 | | |
| Pan, Jingwei |
NCT03388593: Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure. |
|
|
| Recruiting | 3 | 1600 | RoW | rhNRG-1, Neucardin™, Placebo | Zensun Sci. & Tech. Co., Ltd. | Chronic Heart Failure | 02/26 | 02/26 | | |
| Li, Yanhong |
EVALUATE-STEMI, NCT05613426: Effect of Very Early and Rapid Lowering Cholesterol With Evolocumab on Left Ventricular Remodeling in Patients With Anterior STEMI Undergoing Primary PCI |
|
|
| Recruiting | 4 | 330 | RoW | Rosuvastatin 20 mg, Evolocumab 140 mg/1 ml Subcutaneous Solution [REPATHA] | Henan Institute of Cardiovascular Epidemiology | ST Elevation Myocardial Infarction (STEMI) | 12/25 | 12/26 | | |
| Recruiting | 4 | 80 | RoW | Leuprorelin Acetate Depot 3M, Leuprolide acetate Depot 3M | Takeda, Takeda | Central Precocious Puberty | 05/25 | 05/25 | | |
NCT03388593: Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure. |
|
|
| Recruiting | 3 | 1600 | RoW | rhNRG-1, Neucardin™, Placebo | Zensun Sci. & Tech. Co., Ltd. | Chronic Heart Failure | 02/26 | 02/26 | | |
NCT05493709: Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects with Central Precocious Puberty |
|
|
| Recruiting | 3 | 93 | US, RoW | Leuprolide Mesylate, Subcutaneous injection of 42 mg Leuprolide | Foresee Pharmaceuticals Co., Ltd., QPS Holdings LLC, Changchun GeneScience Pharmaceutical Co., Ltd. | Puberty; Precocious, Central | 11/25 | 06/26 | | |
| Not yet recruiting | N/A | 50 | Canada | Treatment bundle of care, Control Group | University Health Network, Toronto | Kidney Transplant, Kidney Failure, Kidney Injury | 01/26 | 04/26 | | |
